{"id":32455,"date":"2017-10-01T11:29:36","date_gmt":"2017-10-01T11:29:36","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=32455"},"modified":"2019-01-10T16:10:32","modified_gmt":"2019-01-10T16:10:32","slug":"uk-prep-guidelines-online-for-comment","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/32455","title":{"rendered":"UK PrEP guidelines: online for comment (Oct 2017)"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-32459\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2017\/08\/BASHH-logo-298x300.png\" alt=\"BASHH logo\" width=\"142\" height=\"151\" \/>New guidelines from BHIVA\/BASHH on the use of HIV pre-exposure prophylaxis (PrEP) 2017 are now\u00a0posted online for comment.<\/strong><\/p>\n<p>The deadline for responses is Friday 29 September 2017.<\/p>\n<p>The evidence-based document\u00a0has been produced to provide guidance\u00a0on best clinical practice in the provision, monitoring and support on PrEP in the UK.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-24693\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2014\/02\/bhiva-logo.png\" alt=\"bhiva logo\" width=\"204\" height=\"86\" \/>Sections\u00a0include:<\/p>\n<ul>\n<li>Evidence for efficacy and safety in different populations.<\/li>\n<li>Risk assessment before\u00a0PrEP.<\/li>\n<li>Prescribing<\/li>\n<li>Monitoring.<\/li>\n<li>Dosing options<\/li>\n<li>Buying generic PrEP<\/li>\n<li>Cost effectiveness<\/li>\n<\/ul>\n<p>The guidelines are aimed at clinical professionals who are directly involved in HIV prevention, and at community advocates and organisations responsible for supporting HIV prevention strategies in those at risk of HIV acquisition.<\/p>\n<p>Please download and comment via the BHIVA website.<br \/>\n<a href=\"http:\/\/www.bhiva.org\/PrEP-guidelines-consultation.aspx\" rel=\"noopener\">http:\/\/www.bhiva.org\/PrEP-guidelines-consultation.aspx<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New guidelines from BHIVA\/BASHH on the use of HIV pre-exposure prophylaxis (PrEP) 2017 are now\u00a0posted online for comment. The deadline for responses is Friday 29 September 2017. The evidence-based document\u00a0has been produced to provide guidance\u00a0on best clinical practice in the &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23,10],"tags":[],"class_list":["post-32455","post","type-post","status-publish","format-standard","hentry","category-guidelines","category-transmission-and-prevention"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/32455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=32455"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/32455\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=32455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=32455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=32455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}